Brian Stevens - 28 Feb 2022 Form 4 Insider Report for BAXTER INTERNATIONAL INC (BAX)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
04 Mar 2022, 16:25:11 UTC
Prior SEC filing
14 Feb 2022
Next SEC filing
23 Mar 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Matthew Rice, as attorney in-fact for Brian Stevens

Key filing fact

Brian Stevens filed Form 4 for BAXTER INTERNATIONAL INC (BAX) on 04 Mar 2022.

Key facts

  • This page summarizes Brian Stevens's Form 4 filing for BAXTER INTERNATIONAL INC (BAX).
  • 5 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 04 Mar 2022, 16:25.

Change

  • Previous filing in this sequence was filed on 14 Feb 2022.
  • Current net transaction value: -$29,268.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BAX transaction

Common Stock, $1 par value

Tax liability

Transaction value
$14,615
Shares
-172
Change %
-1.2%
Price
$84.97
Shares after
13,839
Date
28 Feb 2022
Ownership
Direct
Footnotes
F1
BAX transaction

Common Stock, $1 par value

Award

Transaction value
$0
Shares
+3,567
Change %
+26%
Price
$0.000000
Shares after
17,406
Date
02 Mar 2022
Ownership
Direct
Footnotes
F2
BAX transaction

Common Stock, $1 par value

Award

Transaction value
$0
Shares
+8,918
Change %
+51%
Price
$0.000000
Shares after
26,324
Date
02 Mar 2022
Ownership
Direct
Footnotes
F3
BAX transaction

Common Stock, $1 par value

Tax liability

Transaction value
$14,653
Shares
-172
Change %
-0.65%
Price
$85.19
Shares after
26,151
Date
03 Mar 2022
Ownership
Direct
Footnotes
F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BAX transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+8,269
Change %
Price
$0.000000
Shares after
8,269
Date
02 Mar 2022
Ownership
Direct
Underlying class
Common Stock, $1 par value
Underlying amount
8,269
Exercise price
$85.23
Footnotes
F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on February 28, 2022 from the settlement of vested restricted stock units granted on February 28, 2019.

Footnote F2

The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 2, 2023, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan.

Footnote F3

The reporting person received a grant of restricted stock units which are scheduled to vest on March 3, 2025, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan.

Footnote F4

Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 3, 2022 from the settlement of vested restricted stock units granted on March 3, 2021.

Footnote F5

The options become exercisable in three equal annual installments beginning on March 2, 2023, the first anniversary of the grant date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .